1. Home
  2. Analysis
  3. Risperidone
  4. Abscess-limb

Risperidone and Abscess limb - a phase IV clinical study of FDA data

Summary:

Abscess limb is reported as a side effect among people who take Risperidone (risperidone), especially for people who are male, 10-19 old, also take Ciprofloxacin, and have Crohn's disease.

The phase IV clinical study analyzes which people have Abscess limb when taking Risperidone. It is created by eHealthMe based on reports of 70,786 people who have side effects when taking Risperidone from the FDA, and is updated regularly.

What is Risperidone?

Risperidone has active ingredients of risperidone. It is often used in bipolar disorder. eHealthMe is studying from 72,175 Risperidone users. Check the latest studies of Risperidone.

What is Abscess limb?

Abscess limb (limb infection) is found to be associated with 582 drugs and 621 conditions by eHealthMe. Check the latest studies of Abscess limb.

On Jul, 16, 2026

70,786 people reported to have side effects when taking Risperidone.
Among them, 14 people (0.02%) have Abscess limb.

Could Risperidone cause Abscess limb?

Among these 14 people:

What is the gender of people who have Abscess limb when taking Risperidone? *

  • female: 14.29 %
  • male: 85.71 %

What is the age of people who have Abscess limb when taking Risperidone? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 42.86 %
  • 20-29: 14.29 %
  • 30-39: 28.57 %
  • 40-49: 14.29 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

What are other drugs people take besides Risperidone? *

  1. Allopurinol: 7 people, 50.00%
  2. Metronidazole: 7 people, 50.00%
  3. Hydrochlorothiazide: 7 people, 50.00%
  4. Ciprofloxacin: 7 people, 50.00%
  5. Inflectra: 6 people, 42.86%
  6. Xolair: 4 people, 28.57%
  7. Symbicort: 4 people, 28.57%
  8. Benadryl: 4 people, 28.57%
  9. Bricanyl: 4 people, 28.57%
  10. Divalproex Sodium: 4 people, 28.57%

What are other side effects people have besides Abscess limb? *

  1. Heart Rate Increased: 11 people, 78.57%
  2. High Blood Pressure: 11 people, 78.57%
  3. Cough: 9 people, 64.29%
  4. Nasopharyngitis (inflammation of the nasopharynx): 9 people, 64.29%
  5. Intestinal Obstruction: 7 people, 50.00%
  6. Constipation: 7 people, 50.00%
  7. Flatulence (flatus expelled through the anus): 7 people, 50.00%
  8. Appetite - Increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires): 7 people, 50.00%
  9. Body Temperature Decreased: 7 people, 50.00%
  10. Furuncle (infection of the hair follicle): 7 people, 50.00%

What are the existing conditions these people have? *

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 7 people, 50.00%
  2. Dyspnea (difficult or laboured breathing): 4 people, 28.57%
  3. Asthma: 4 people, 28.57%
  4. Drug Dependence: 2 people, 14.29%
  5. Delirium (wild excitement): 2 people, 14.29%
  6. Mania (a state of abnormally elevated or irritable mood): 1 person, 7.14%
  7. Angiomyolipoma (most common benign tumour of the kidney): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Risperidone and have Abscess limb?

- Check whether Abscess limb is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Risperidone:

Abscess limb treatments and more:

How severe was Abscess limb and when was it recovered:

Expand to all the drugs that have ingredients of risperidone:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Risperidone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abscess limb:

Browse all the conditions that are associated with Abscess limb:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on risperidone (the active ingredients of Risperidone) and Risperidone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.